Development Level

Tbio 4 | 10,625
Tclin 1 | 602

IMPC Term

decreased circulating serum al... 2 | 79
abnormal behavior 1 | 226
abnormal tooth morphology 1 | 24
decreased circulating fructosa... 1 | 31
decreased circulating glucose ... 1 | 121
decreased circulating sodium l... 1 | 18
decreased hemoglobin content 1 | 53
decreased pulmonary respirator... 1 | 4
hyperactivity 1 | 108
increased circulating HDL chol... 1 | 63
increased circulating LDL chol... 1 | 15
increased circulating alanine ... 1 | 11
increased circulating alkaline... 1 | 119
increased circulating bilirubi... 1 | 16
increased circulating choleste... 1 | 53
increased circulating free fat... 1 | 17
increased circulating triglyce... 1 | 24
increased grip strength 1 | 83
increased hemoglobin content 1 | 45
increased mean corpuscular hem... 1 | 25
straub tail 1 | 26

Disease

ovarian cancer 5 | 8,484
Alzheimer's disease 4 | 644
Dementia 4 | 129
glioblastoma 4 | 5,572
interstitial cystitis 4 | 2,299
malignant mesothelioma 4 | 3,162
medulloblastoma, large-cell 4 | 6,234
Cancer 3 | 2,346
Parkinson's disease 3 | 364
Schizophrenia 3 | 501
oligodendroglioma 3 | 2,849
osteosarcoma 3 | 7,933
post-traumatic stress disorder 3 | 45
primitive neuroectodermal tumor 3 | 3,031
psoriasis 3 | 6,685
Alcohol dependence 2 | 107
Amphetamine-Related Disorders 2 | 74
Amyloidosis 2 | 68
Attention deficit hyperactivity disorder 2 | 156
Autistic Disorder 2 | 320
Bipolar Disorder 2 | 266
Breast cancer 2 | 3,094
Cerebrovascular disease 2 | 231
Cocaine-Related Disorders 2 | 88
Cognition Disorders 2 | 23
Heroin dependence 2 | 30
Hypertension 2 | 287
Major Depressive Disorder 2 | 106
Metabolic syndrome X 2 | 155
Multiple Sclerosis 2 | 498
Nerve Degeneration 2 | 73
Neurodegenerative disease 2 | 383
Obesity 2 | 616
Panic disorder 2 | 55
Schizoaffective disorder 2 | 33
Seizures 2 | 95
Substance abuse 2 | 55
Toxic encephalopathy 2 | 131
astrocytoma 2 | 1,493
atypical teratoid/rhabdoid tumor 2 | 1,095
diabetes mellitus 2 | 1,663
intraductal papillary-mucinous adenoma (IPMA) 2 | 2,956
intraductal papillary-mucinous carcinoma (IPMC) 2 | 2,988
invasive ductal carcinoma 2 | 2,950
lung cancer 2 | 4,466
medulloblastoma 2 | 1,524
nephrosclerosis 2 | 329
obsessive-compulsive disorder 2 | 34
pancreatic cancer 2 | 2,300
pilocytic astrocytoma 2 | 3,086
posterior fossa group A ependymoma 2 | 1,511
posterior fossa group B ependymoma 2 | 1,530
primary pancreatic ductal adenocarcinoma 2 | 1,271
Adenocarcinoma 1 | 115
Age related macular degeneration 1 | 84
Agoraphobia 1 | 16
Alcoholic Intoxication, Chronic 1 | 41
Amnestic disorder 1 | 37
Animal Mammary Neoplasms 1 | 136
Anorexia nervosa 1 | 59
Anoxia 1 | 33
Aphasia 1 | 22
Brain disease 1 | 83
Bulimia nervosa 1 | 15
Calculus in biliary tract 1 | 2
Carotid Artery Diseases 1 | 11
Cerebral amyloid angiopathy 1 | 9
Child Development Disorders, Pervasive 1 | 55
Deafness 1 | 18
Depressive disorder 1 | 48
DiGeorge syndrome 1 | 46
Drug-Induced Liver Injury 1 | 118
Eating disorder 1 | 24
Fibromyalgia 1 | 22
Gilles de la Tourette syndrome 1 | 47
Gliosis 1 | 16
Hyperglycemia 1 | 120
Hyperhomocysteinemia 1 | 34
Hyperlipidemia 1 | 25
Inflammation 1 | 109
Liver disease 1 | 219
Lung Neoplasms 1 | 171
Lysosomal storage disease 1 | 11
Mammary Neoplasms 1 | 410
Myocardial Infarction 1 | 126
Neonatal abstinence syndrome 1 | 9
Neoplasm Invasiveness 1 | 127
Nicotine dependence 1 | 53
Pain 1 | 70
Pain agnosia 1 | 99
Parkinson Disease 1 | 102
Pathological accumulation of air in tissues 1 | 11
Pheochromocytoma 1 | 22
Sensorineural hearing loss 1 | 107
Substance Withdrawal Syndrome 1 | 52
Tonic-clonic epilepsy 1 | 47
Velocardiofacial syndrome 1 | 45
head and neck cancer and chronic obstructive pulmonary disease 1 | 237
interstitial lung disease 1 | 291
nervous system disorder 1 | 53

Tissue

Blood and immune system 5 | 17,995
Cardiovascular System 5 | 17,958
Digestive Tract 5 | 18,473
Endocrine System 5 | 18,512
Female tissues 5 | 18,647
Liver and Pancreas 5 | 18,136
Male tissues 5 | 17,969
Nervous System 5 | 18,561
Respiratory system 5 | 17,484
Skin and soft tissues 5 | 18,115
Urinary Tract 5 | 18,444

Target Family

Non-IDG 4 | 11,971
Enzyme 1 | 4,146

Grant Application

5R00AG032361-03 5 | 5
3P41RR001209-23S1 157 | 157
5P41RR001209-22 157 | 157
5P41RR001209-23 157 | 157
2P51RR000165-51 139 | 139
5P51RR000163-52 136 | 136
5P51RR000163-51 132 | 132
5P51RR000165-50 130 | 130
2P51RR000163-50 128 | 128
5P51RR000164-48 127 | 127
5P51RR000164-50 125 | 125
5P51RR000164-49 112 | 112
5P51RR000165-49 106 | 106
5P41RR001646-19 103 | 103
5P41RR001646-20 103 | 103
7P51RR000163-41 100 | 100
2P41RR011823-16 99 | 99
5P51RR000163-42 98 | 98
5P51RR000163-43 98 | 98
5P41RR001081-24 94 | 94
5P41RR001646-18 90 | 90
5P41RR015301-09 82 | 82
5P51RR000167-49 78 | 78
5P41RR002250-26 65 | 65
5P51RR000168-40 65 | 65
5P51RR000168-41 65 | 65
5P41RR001646-27 64 | 64
5P51RR000165-40 63 | 63
5M01RR000188-45 60 | 60
3P41RR010888-05S1 59 | 59
5M01RR000030-40 58 | 58
5M01RR000096-39 57 | 57
5P41RR000954-25 57 | 57
5P41RR000954-26 57 | 57
2P41RR000954-33 56 | 56
5P41RR010888-14 56 | 56
5P41RR012408-13 55 | 55
5M01RR000188-46 53 | 53
5P41RR001646-28 52 | 52
5P51RR000167-48 52 | 52
5P51RR000168-49 52 | 52
5P41RR001646-29 51 | 51
2P41RR002250-25 50 | 50
5M01RR000188-47 50 | 50
5P51RR000166-39 47 | 47
5M01RR000043-40 46 | 46
5P51RR000168-50 46 | 46
5P41RR010888-15 45 | 45
5P41RR015301-08 45 | 45
5P41RR004050-13 44 | 44
5M01RR000847-37 43 | 43
5P41RR004050-12 43 | 43
5P51RR000167-50 43 | 43
5P51RR000169-50 43 | 43
5P41RR000954-34 42 | 42
2P41RR004050-21 41 | 41
5P41RR010888-13 41 | 41
5P51RR000168-48 41 | 41
5P51RR000167-40 40 | 40
5P41RR015301-07 39 | 39
5P51RR000164-39 39 | 39
5P51RR000168-39 39 | 39
2P51RR000169-49 38 | 38
5P51RR000169-48 38 | 38
5P41RR004050-23 37 | 37
5P51RR013986-13 37 | 37
3P51RR000167-46S2 36 | 36
5P41RR001008-25 36 | 36
5M01RR000043-49 35 | 35
5P20RR021905-04 35 | 35
5P41RR004050-22 35 | 35
5M01RR000040-40 34 | 34
5P20RR016481-10 34 | 34
5P41RR001315-19 34 | 34
3P60DE013079-01S1 32 | 32
5M01RR000833-26 32 | 32
5P20RR016481-11 32 | 32
5P20RR020152-07 32 | 32
5P41RR000862-38 32 | 32
5P51RR000166-49 32 | 32
5P60DE013079-02 32 | 32
5S06GM008037-29 32 | 32
5S06GM008037-30 32 | 32
5U41RR007707-10 32 | 32
2P20RR016480-09 31 | 31
5M01RR000827-34 31 | 31
5P41RR002250-24 31 | 31
5P41RR005959-22 31 | 31
5P41RR018522-08 31 | 31
3P60DE013079-03S1 30 | 30
5P20RR016457-10 30 | 30
5P41RR000592-40 30 | 30
5P41RR000592-41 30 | 30
5P41RR000862-36 30 | 30
5P41RR007707-17 30 | 30
5P51RR000166-48 30 | 30
5P60DE013079-03 30 | 30
5P60DE013079-04 30 | 30
5U54AI057168-09 30 | 30
5U54AI057168-10 30 | 30
2U54AI057168-06 29 | 29

This is where graphics are reside..
Name Gene Development Level Target Family Log Novelty  Pubmed Score  Antibody Count  Knowledge Availability 
Apolipoprotein E APOE Tbio Non-IDG -4.17470 15380.4 788
Protein KIBRA WWC1 Tbio Non-IDG -1.88892 84.4 96
Brain-derived neurotrophic factor BDNF Tbio Non-IDG -3.94336 9826.7 594
Sortilin-related receptor SORL1 Tbio Non-IDG -2.21932 197.0 159
Catechol O-methyltransferase COMT Tclin Enzyme -3.43022 2841.1 409